Regulus Therapeutics Inc. - Bathi operasional EBITDA RGLS
Regulus Therapeutics (RGLS) relies on partnerships with biotech giants to combat kidney pathologies. The EBITDA volume on this GURU.Markets platform chart demonstrates resilience, where captures the current value of the indicator. Efficiency is confirmed by transparent orphan drug tests, the management's skilled fundraising, and diversified oligonucleotide production via external contractors for the development of miRNA drugs.
Regulus Therapeutics Inc. (RGLS) - rincian metrik lan laporan keuangan
- rega saham lan target rega konsensus:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Utang Agregat marang Modal Regulus Therapeutics|RGLS - Utang jangka dawa marang modal|Rasio tanggungan utang jangka cendhak marang modal Regulus Therapeutics, Inc.|RGLS - Gunggung utang perusahaan|Utang-utang marang nilai buku Regulus Therapeutics|RGLS - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Regulus Therapeutics|Rasio cepet regulusrx.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
RGLS - Bathi resik perusahaan|Bathi forward Regulus Therapeutics|RGLS - Pangali P/E|Rasio prakiraan rega marang bathi regulusrx.com|RGLS - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Regulus Therapeutics|RGLS - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Regulus Therapeutics|RGLS - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan regulusrx.com|RGLS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Regulus Therapeutics
Ringkesan analitik perusahaan:Regulus Therapeutics
An analysis of the EBITDA_Co trend confirms the status of Regulus Therapeutics (RGLS) as a high-tech issuer implementing robotic miRNA screening to accelerate drug development. This metric captures the actual cash flow from core operations, allowing investors to assess the stability of operating margins and the risk of prolonged drawdowns should business model efficiency decline during periods of market cooling.
Pesaing Regulus Therapeutics (RGLS)
Tempus - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|QGEN: Bathi operasional sadurunge ngurangi amortisasi|IONS - Bathi operasional EBITDA|Repligen (RGEN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|RNA - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi CRSP|WGS: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi RARE (Ultragenyx Pharmaceutical)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi BEAM|Bathi operasional EBITDA SRPT (Sarepta)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TWST|10x Genomics Corp - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Intellia Corp|Stoke Therapeutics (STOK) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|biolifesolutions.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|WVE (Wave Life Sciences Ltd.) - Bathi operasional EBITDA|Bathi operasional EBITDA Maze Therapeutics, Inc.|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sionna Pharma (SION)|PRME: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi operasional EBITDA TSHA (Taysha Gene Therapies)|uniqure.com (QURE) - Bathi sadurunge bunga, pajak, lan amortisasi|MGTX: Bathi operasional sadurunge ngurangi amortisasi|RGNX - Bathi operasional EBITDA|SLDB (Solid Bio) - Bathi operasional sadurunge ngurangi amortisasi|OCGN: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|PACB (Pacific Biosciences) - Bathi operasional EBITDA|benitec.com (BNTC) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA DSGN|Bathi operasional sadurunge ngurangi amortisasi Rocket Pharma RCKT|Bathi sadurunge mbayar bunga, pajak, lan amortisasi 4D Molecular Therapeutics Inc FDMT|Pendapatan operasional sadurunge ngurangi amortisasi Lexeo Therapeutics Inc. (LXEO)|KRRO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi EDIT (editasmedicine.com)|SLN: Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi ProQR Therapeutics PRQR|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Codexis Inc|Bathi sadurunge mbayar bunga, pajak, lan amortisasi SGMO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Nautilus Biotechnology (NAUT)|Pendapatan operasional sadurunge ngurangi amortisasi metagenomi.co|Bathi operasional EBITDA DTIL (Precision BioSciences, Inc.)|GBIO: Bathi operasional sadurunge amortisasi|BOLD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|XCUR (Exicure, Inc.) - Bathi operasional sadurunge amortisasi|IMNN: Bathi operasional EBITDA|Phio Pharmaceuticals Corp. (PHIO) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Mustang Bio Inc|RNAZ: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA BNGO|APDN - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi operasional EBITDA BLUE (bluebird bio, Inc.)|Bathi operasional sadurunge potongan amortisasi ImmunoPrecise Antibodies Ltd|OMGA: Bathi operasional sadurunge ngurangi amortisasi|OMIC - Bathi operasional EBITDA|Syros (SYRS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|TBIO (Telesis Bio, Inc) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi TCON|Bathi operasional EBITDA unitybiotechnology.com
